| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.052 | 9.339 | 8.500 | 13.548 | 32.613 | 31.047 |
| Total Income - EUR | - | - | - | - | 4.052 | 9.339 | 8.500 | 13.548 | 32.613 | 33.137 |
| Total Expenses - EUR | - | - | - | - | 338 | 1.121 | 1.129 | 1.545 | 1.864 | 17.576 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.714 | 8.219 | 7.371 | 12.003 | 30.750 | 15.561 |
| Net Profit/Loss - EUR | - | - | - | - | 3.593 | 7.938 | 7.168 | 11.658 | 25.928 | 12.398 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Balasan Ob-Gyn S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 913 | 546 | 213 | 0 | 0 | 47.170 |
| Current Assets | - | - | - | - | 2.863 | 8.001 | 10.028 | 15.519 | 29.574 | 21.222 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 565 | 812 | 754 | 1.214 | 9.938 | 0 |
| Cash | - | - | - | - | 2.297 | 7.190 | 9.274 | 14.305 | 19.635 | 21.222 |
| Shareholders Funds | - | - | - | - | 3.635 | 8.403 | 9.826 | 15.309 | 25.977 | 12.446 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 157 | 160 | 506 | 286 | 3.794 | 55.947 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Balasan Ob-Gyn S.r.l.